Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bone Metabolism in Adolescents Undergoing GLP-1 Receptor Agonist Therapy

NCT06903923 is registered in ClinicalTrials.gov with University of Virginia as lead sponsor.

NCT NCT06903923
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06903923 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bone Metabolism in Adolescents Undergoing GLP-1 Receptor Agonist Therapy
Lead sponsor
University of Virginia
Phase
Phase 2
Overall status
Recruiting
Start date
July 31, 2025
Completion date
April 30, 2030
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bone density, bone strength, glp - 1, lifestyle modification, obesity, obesity in children